240 related articles for article (PubMed ID: 29625594)
21. SMARCB-1 deficient squamous cell carcinoma of a mediastinal cyst.
Nishimura Y; Yoshida A; Yonemori K; Motoi N; Tamura K; Hiraoka N; Mori T
Pathol Int; 2018 Oct; 68(10):563-566. PubMed ID: 30216599
[TBL] [Abstract][Full Text] [Related]
22. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.
Agaimy A; Koch M; Lell M; Semrau S; Dudek W; Wachter DL; Knöll A; Iro H; Haller F; Hartmann A
Am J Surg Pathol; 2014 Sep; 38(9):1274-81. PubMed ID: 24832165
[TBL] [Abstract][Full Text] [Related]
23. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract][Full Text] [Related]
24. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
Agaimy A; Rau TT; Hartmann A; Stoehr R
Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
[TBL] [Abstract][Full Text] [Related]
25. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
[TBL] [Abstract][Full Text] [Related]
26. [SMARCB1 (INI1)-deficient sinonasal carcinoma: a clinicopathological analysis of six cases].
Tang SJ; Zhai CW; Yuan CC; Zhang JH; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):47-51. PubMed ID: 31914534
[No Abstract] [Full Text] [Related]
27. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
[TBL] [Abstract][Full Text] [Related]
28. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
[TBL] [Abstract][Full Text] [Related]
29. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
[No Abstract] [Full Text] [Related]
30. [Expression of SMARCA4(BRG1) and SMARCB1(INI1) in dedifferentiated and undifferentiated endometrial carcinomas and their correlations with clinicopathological features].
Bi R; Yu L; Tu XY; Ge HJ; Cheng YF; Chang B; Cai X; Jiang WH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):590-595. PubMed ID: 31422588
[No Abstract] [Full Text] [Related]
31. Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers.
Forrest SJ; Al-Ibraheemi A; Doan D; Ward A; Clinton CM; Putra J; Pinches RS; Kadoch C; Chi SN; DuBois SG; Leavey PJ; LeBoeuf NR; Mullen E; Collins N; Church AJ; Janeway KA
Clin Cancer Res; 2020 Jun; 26(12):2882-2890. PubMed ID: 32122923
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
[TBL] [Abstract][Full Text] [Related]
33. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
34. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.
Kakkar A; Antony VM; Pramanik R; Sakthivel P; Singh CA; Jain D
Hum Pathol; 2019 Jan; 83():59-67. PubMed ID: 30120966
[TBL] [Abstract][Full Text] [Related]
35. Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors.
Zamecnik M; Rychnovsky J; Syrovatka J
Int J Surg Pathol; 2018 May; 26(3):245-249. PubMed ID: 29166820
[TBL] [Abstract][Full Text] [Related]
36. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
37. SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma.
Gandhi JS; Alnoor F; Sadiq Q; Solares J; Gradowski JF
Pathol Res Pract; 2021 Mar; 219():153341. PubMed ID: 33581550
[TBL] [Abstract][Full Text] [Related]
38. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
39. SMARCB1/INI1/BAF47- deficient pleural malignant mesothelioma with rhabdoid features.
Kimura N; Hasegawa M; Hiroshima K
Pathol Int; 2018 Feb; 68(2):128-132. PubMed ID: 29316066
[TBL] [Abstract][Full Text] [Related]
40. [SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].
Agaimy A; Hartmann A
Pathologe; 2021 Nov; 42(6):571-577. PubMed ID: 34609565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]